GSK Gate2Health and IE School of Science & Technology: an alliance to accelerate healthcare innovation

The third GSK Gate2Health meeting reinforces collaboration between industry and academia, presenting the GSK–IE Biopharma & AI Gateway—a program aimed at accelerating the research, development, and commercialization of new treatments through artificial intelligence and advanced technologies.

Artificial intelligence and emerging technologies are opening up new possibilities to transform research, drug development, and healthcare. One year after the launch of Gate2Health, GSK held the third meeting of its open innovation community in Madrid, alongside IE School of Science & Technology as a strategic partner to foster education, share knowledge, and promote the development of solutions with real-world impact in healthcare.

Innovation as a bridge between research and impact

The gathering, opened by Florencia Davel, President of GSK Spain, and Ikhlaq Sidhu, Dean of IE School of Science & Technology, focused on collaboration between the biopharmaceutical industry and academia as a driver to transform healthcare systems. Throughout the day, success stories in digital transformation and examples of how artificial intelligence can accelerate drug discovery, optimize clinical trials, and redefine traditional research and development workflows were shared.

GSK–IE Biopharma & AI Gateway 

As part of the gathering, the GSK–IE Biopharma & AI Gateway was presented, developed from the agreement signed between GSK and IE in 2025. The program aims to accelerate the research, development, and commercialization of new medicines and vaccines through artificial intelligence and other advanced technologies. This initiative connects industry expertise with academic knowledge and entrepreneurial talent, and is carried out alongside the IEX Research Xcelerator, IE’s global center for technological innovation.

Technology applied to real-world healthcare challenges

Oncohematología

ejemplos de transformación digital y nuevas aplicaciones de la IA para acelerar procesos de investigación y desarrollo

Prevención

soluciones tecnológicas orientadas a anticiparse a la enfermedad y mejorar la capacidad de respuesta del sistema sanitario

Salud respiratoria

casos de uso de inteligencia artificial y tecnologías innovadoras para optimizar procesos asistenciales y avanzar hacia una atención más eficiente.

From innovation to implementation

Beyond showcasing emerging technologies, the session focused on taking them from the pilot stage to real-world practice. Collaboration among companies, academic institutions, healthcare professionals, and entrepreneurs makes it possible to identify unmet needs, validate solutions, and accelerate their adoption into clinical settings.

The event also made room for the experiences of IE alumni who have launched health-related business ventures, alongside various Gate2Health partners who shared key takeaways on the challenges of implementing innovative solutions within the healthcare system.